Thymoquinone (TQ) has a variety of beneficial properties including antioxidant and antiinflammatory activities. In this study, the effect of TQ on biochemical changes and coagulopathy accompanying liver fibrosis in BALB/c mice was investigated. Fibrosis was induced by intraperitoneal injection of carbon tetrachloride (0.5 ml /kg) for 4 weeks. TQ was administrated at three dose levels (2, 4 and 8 mg/kg) in drinking water, starting 7 days before CCl 4 injection and continuing during the CCl 4 administration period (4 weeks). CCl 4 raised serum alanine aminotransferase activity as well as hepatic malondialdehyde content and myeloperoxidase activity. This was accompanied by a significant decrease in superoxide dismutase, catalase activities and reduced glutathione level in liver. Treatment of mice with TQ ameliorated the hepatotoxicity induced by CCl 4 , as evidenced by disappearance of fibrosis. Serum alanine aminotransferase activity, hepatic malondialdehyde content and myeloperoxidase activity decreased significantly while antioxidant enzymes activities rose. Prothrombin time and activated partial thromboplastin time were significantly elevated after injection of CCl 4 as compared to normal control group. TQ potentiated the effect of CCl 4 on the coagulation parameters. Our results showed that TQ ameliorates hepatic fibrosis induced by CCl 4 . However, it did not improve the coagulopathy induced in this model. Consequently, the use of TQ may be not always beneficial in different stages of chronic liver disease.
INTRODUCTION
Hepatic fibrosis results from a sustained wound healing in response to chronic liver injury (Friedman, 2003). It has multiple causes ranging from viral infections and alcohol abuse to autoimmune disease, non-alcoholic fatty liver disease and developmental anomalies (Rebecca, 2006). If liver is treated properly at stage of fibrosis, cirrhosis could be prevented (Riley and Bhatti, 2001).
Decreased levels of most procoagulant factors and thrombocytopenia are the main haemostatic abnormalities associated with chronic liver disease. As a consequence, this condition was, until recently, considered as a prototype acquired coagulopathy. Little attention had been paid to the fact that, similar to procoagulant factors, their anticoagulant counterparts (namely protein C and antithrombin) are also reduced to the same extent. Therefore, the possibility that a rebalance of coagulation could take place in chronic liver disease has been ignored for many years (Tripodi et al., 2011).
Neubauer et al. have shown that fibrin accumulates in the liver during acute as well as chronic experimental liver injury (Neubauer et al., 1995). Thrombin is responsible for the conversion of fibrinogen to fibrin. There are at least two mechanisms through which thrombin generation could be involved in fibrogenesis. Firstly, clot formation by itself leads to flow disturbance and local hypoxia which is a cofactor for fibrosis. Secondly, thrombin binds to several receptors that belong to the family of protease activated receptors (PAR). PAR-1 is upregulated in chronic injury leading to proliferation of hepatic Carbon tetrachloride (CCl 4 )-induced liver fibrosis model is similar to the human disease, from the standpoint of morphology and biochemical aspects of collagen metabolism (Tamayo, 1983). The hepatotoxic effect of CCl 4 is thought to result from its reductive dehalogenation by the CYP450 enzyme system to the highly reactive free radical, trichloromethyl radical (CCl 3 . ), leading to lipid peroxidation and activation of Kupffer cells, that is accompanied by the production of proinflammatory mediators ( Previous studies demonstrated that Nigella sativa may be successful in the prevention of liver fibrosis in rabbits (Turkdogan et al., 2001). Thymoquinone (TQ), the main constituent of the volatile oil obtained from Nigella sativa seeds, has been subjected to a range of pharmacological investigations in the past years. Its oral administration protected several organs against oxidative damage induced by a variety of free radical-generating agents. It is an efficient cytoprotective agent against hepatotoxicity by a combination of two mechanisms: decreasing hepatic lipid peroxidation (Al-Gharably et al., 1997) and preventing depletion of intracellular glutathione (Daba and Abdel-Rahman, 1998).
Using the CCl 4 -induced liver fibrosis model, the aim of this study was to investigate the effect of TQ administration on fibrosis progression and coagulopathy accompanying it, and hence the merits or demerits of TQ use in chronic liver diseases.
MATERIALS AND METHODS

Drugs and chemicals
Thymoquinone and carbon tetrachloride were purchased from Sigma Aldrich Co (St. Louis, MO. USA). All the remaining chemicals were of the highest analytical grade.
Animals and experimental design
Adult BALB/c male mice, weighting 30-35 gm, were obtained from the breeding colony at the animal house of Theodor Bilharz Research Institute. Mice were housed in cages and provided free access to pelleted food and drinking water. The animal experiments described comply with the ethical principles and guidelines for the care and use of laboratory animals adopted by the National Egyptian Community.
BALB/c mice were divided into 8 groups (8 mice in each) as follows:
Group 1: mice received corn oil (5 µl/g i.p.) biweekly for 4 weeks.
Group 2: mice received CCl 4 (5 µl/g as a 1:9 mixture with corn oil) i.p. biweekly for 4 weeks.
Group 3: mice received TQ (2 mg/kg/day p.o) in drinking water for 5 weeks and were injected with corn oil (5 µl/g i.p.) biweekly starting from the second week and continuing during the TQ treatment period.
Group 4: mice received TQ (4 mg/kg/day p.o) in drinking water for 5 weeks and injected with corn oil (5 µl/g i.p.) biweekly starting from the second week and continuing during the TQ treatment period.
Group 5: mice received TQ (8 mg/kg/day p.o) in drinking water for 5 weeks and injected with corn oil (5 µl/g i.p.) biweekly starting from the second week and continuing during the TQ treatment period. Twenty four hours after the last corn oil or CCl 4 injection, blood samples were taken from mice by retro-orbital puncture. A part was collected on 3.8% trihydrated trisodium citrate solution and centrifuged at 3000 rpm for 5 min. The obtained clear non-haemolysed plasma was used for estimation of prothrombin time (PT) and activated partial thromboplastin time (aPTT).
The other part of blood sample was left to clot at room temperature and centrifuged at 3000 rpm for 5 min in order to obtain a clear non-haemolysed serum. The serum was used for estimation of liver function parameters.
After the collection of the blood samples all mice were sacrificed by cervical dislocation. The liver was rapidly removed, blotted dry and weighed. Samples of the liver were fixed with 10% formal saline for histopathological study. Liver sample from each mouse was homogenized in ice cold normal saline to obtain a 10% (w/v) homogenate. The homogenates were centrifuged at 10000 rpm for 30 min at 4°C and supernatants were stored at −70°C until biochemical assays could be performed.
2.3.
Determination of serum alanine aminotransferase (ALT) activity
The serum ALT activity was determined by standard spectrophotometric procedure as described by Reitman and Frankel (1957) using commercially available diagnostic kit supplied by Quimica Clinica Aplicada (S.A., Spain).
Determination of lipid peroxide level
Lipid peroxidation was assessed by measuring malondialdehyde (MDA) level in the liver homogenate supernatants according to Mihara and Uchiyama (1978).
Determination of reduced glutathione (GSH) content
Liver homogenate content of GSH was measured according to method of Ellman (1957).
Determination of antioxidant enzymes activities
Determination of Superoxide Dismutase Activity
Superoxide dismutase (SOD) activity was determined by calculating the difference between autooxidation of pyrogallol alone and in the presence of homogenate that contained SOD according to the method described by Marklund (1985).
Determination of Catalase Activity
Catalase (CAT) activity was determined based on the decrease in light absorption at 240 nm because of the decomposition of hydrogen peroxide by catalase (Claribone, 1985).
Determination of myeloperoxidase (MPO) activity
MPO activity was measured in liver homogenate according to method described by Pinegin et al. (1995).
Determination of total protein
Total protein of liver homogenate supernatants was determined according to Lowry et al. (1951).
Determination of coagulation parameters
Determination of PT and aPTT was done using test reagent kits (DiaMed AG, Cressier sur Morat, Switzerland) according to the methods described by Quick et al. (1935) and Bell and Alton (1954), respectively.
Histopathological examination of liver sections
Autopsy samples were taken from the liver of rats in different groups then fixed in 10% formal saline. Serial dilutions of alcohol (methyl, ethyl, and absolute ethyl) were used. Specimens were cleared in xylene embedded in paraffin at 56•C in hot air oven for 24 h. Paraffin bees wax tissue blocks were prepared for sectioning at 4 μm thickness by a sledge microtome. The obtained tissue sections were collected on glass slides, deparaffinized, and stained by hematoxylin and eosin stain for histopathological examination through the light microscope.
Statistical analysis
Results are expressed as the mean ± SEM and the different groups were compared using one way analysis of variance (ANOVA) followed by TukeyKramer test for multiple comparisons.
RESULTS
Serum ALT activity, hepatic MDA and GSH content
We examined the hepatoprotective effect of TQ on CCl 4 -induced fibrosis in mice. CCl 4 injection increased the serum alanine aminotransferase (ALT) activity by 22-folds, compared with control group. Administration of TQ at doses of 2, 4 and 8 mg/kg to mice treated with CCl 4 significantly reduced serum ALT activity by approximately 19%, 46% and 42%, respectively, as compared to the CCl 4 treated group. Hepatic malondialdehyde (MDA) level increased significantly in the CCl 4 -injected mice by 150% as compared to the control group. Administration of 4 and 8 mg/kg of TQ to CCl 4 treated group reduced significantly hepatic MDA content by approximately 32% and 29%, respectively, as compared to the CCl 4 treated group.
On the other hand, hepatic glutathione content in the CCl 4 -injected mice decreased by almost 42.51% compared to mice treated with corn oil. Administration of TQ at a dose of 2 mg/kg to mice treated with CCl 4 significantly increased hepatic GSH content by approximately 55%, while 4 and 8 mg/kg of TQ significantly increased hepatic GSH by approximately 2 folds as compared to the CCl 4 treated group (Table 1) .
Antioxidant enzymes and myeloperoxidase activities
As shown in Administration of different doses of TQ to corn oil treated group did not change the previous parameters measured in serum or liver homogenate compared to the control group (results not shown).
Coagulation parameters
Administration of TQ at doses of 2, 4 and 8 mg/kg to BALB/c mice significantly increased PT value by approximately 26.5%, 30.17% and 29.39% respectively as compared to the control group. Similarly, aPTT value increased by 24.13%, 31.55% and 29.07% respectively as compared to the control group (Figure 1 ). Administration of TQ at a dose of 2 mg/kg to mice treated with CCl 4 did not significantly change PT value while it increased aPTT value by 9% as compared to the CCl 4 treated group. TQ at doses of 4 and 8 mg/kg increased PT value by approximately 17%, while they increased aPTT value by approximately 21% and 18%, respectively, as compared to the CCl 4 treated group (Figure 2) .
Histopathological examination of liver sections
Liver section from corn oil control mice showed normal morphological and histological features without inflammation or necrosis (Figure 3  A) . In contrast, the liver injured by chronic CCl 4 administration displayed an obvious infiltration of inflammatory cells (M) along with necrotic damages (N) and appearance of focal area of fibrosis (F) (Figure 3 
DISCUSSION
The current study aimed to investigate the effect of TQ on biochemical changes and coagulopathy accompanying fibrosis induced by CCl 4 injection in BALB/c mice.
Treatment with CCl 4 resulted in a significant increase in serum ALT activity. Lipid peroxidation measured as MDA content in liver tissue was increased. CCl 4 -induced lipid peroxidation may account for the release of intracellular enzymes such as amino transferases into the extracellular compartments, including blood serum (Zimmerman, 1978).
We found also that hepatocellular injury provoked by administration of CCl 4 caused a decrease of hepatic GSH. This depletion was explained on the basis that CCl 4 , is hydrolyzed by CYP450 and activated to the trichlorometlyl radical (CCl 3 . ) which is conjugated by GSH that detoxifies this toxic metabolite and facilitates its excretion. Accordingly, exhaustion of intracellular substances such as glutathione, which is capable of preferentially conjugating with the toxic metabolites, is one of the sequences of Similarly, SOD and CAT activities were significantly decreased by injection of CCl 4 . This finding is in accordance with Ko and Lim (2006) and can be explained on the basis that SOD and CAT are part of the enzymatic antioxidant defense systems that have been developed by cells to cope up with the ROS and other free radicals. When a condition of oxidative stress establishes, the defense capacities against ROS becomes insufficient (Wei, 1998).
Free radicals generated by CCl 4 metabolism activate Kupffer cells. Neutrophils are attracted and activated by the cytokines secreted by the activated Kupffer cells. Infiltration of neutrophils into tissues is commonly assessed by changes in activity of myeloperoxidase (MPO), an enzyme found primarily in neutrophils that produce hypochlorous acid (HOCl) from hydrogen peroxide (H 2 O 2 ) and chloride anion (Cl -). In this study, we observed an increase of the MPO activity in the liver tissues of mice treated with CCl 4 which may indicate that neutrophil accumulation contributes to CCl 4 -induced liver injury. This finding was confirmed by the histopathological study showing increased number of inflammatory cells.
In the present work, administration of TQ one week before and during CCl 4 injection period elicited hepatoprotective effect. This was demonstrated by the significant decrease in ALT activity at different doses (2, 4 and 8 mg/kg). These doses prevented depletion of intracellular GSH. The elevation of hepatic GSH level observed in CCl 4 groups treated with TQ may be explained by the ability of TQ to induce antioxidant enzymes like quinone reductase in mice liver (Nagi and Almakki, 2009; Prestera et al., 1993). Prevention of GSH depletion by TQ leading to maintenance of cell membrane integrity may explain the reduction of serum ALT leakage (Daba and Abdel-Rahman, 1998).
Concerning the effect of TQ on hepatic antioxidant enzymes, we found that treatment of CCl 4 -injected mice with TQ (2 mg/kg) did not significantly change SOD and CAT activities, while the other doses (4 and 8 mg/kg) significantly increased enzymes activities. This increase could presumably be explained as a consequence of the decrease in these enzymes substrates (superoxide radical or free radicals) due to the reported superoxide radical scavenging effect of TQ ( In conclusion, our work showed the ability of TQ to protect liver from chemically-induced fibrosis due to its antioxidant and anti-inflammatory effects. However, it may worsen the coagulopathy associated with fibrosis. This finding pointed to that TQ may not be always beneficial in all cases of chronic liver diseases. Further studies will be needed to investigate the mechanistic effect of TQ on blood coagulation. 
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